Victor J. Torres
Infectious Diseases · 2008–2023
A researcher in the Science corpus: 21 papers; trusts 15 researchers and is trusted by 13 researchers here, as inferred from the citation graph.
Subfields
- Infectious Diseases — 180 citations into it; #54 of 589 by trust here, #69 by citations
- Molecular Biology — 162 citations into it; #13,032 of 17,773 by trust here, #4,775 by citations
- Public Health, Environmental and Occupational Health — 65 citations into it; #1,203 of 2,368 by trust here, #739 by citations
- Genetics — 53 citations into it
- Clinical Biochemistry — 42 citations into it
- Immunology — 41 citations into it; #1,177 of 2,160 by trust here, #692 by citations
- Microbiology — 29 citations into it; #157 of 213 by trust here, #54 by citations
- Epidemiology — 25 citations into it
Whom Victor J. Torres trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Victor J. Torres overall
Papers from Victor J. Torres's perspective
Ordered by how strongly the researchers Victor J. Torres trusts endorse each paper. Same corpus, a different order for every researcher.
- Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA (Nature Medicine)
- Staphylococcus aureus Panton-Valentine Leukocidin Causes Necrotizing Pneumonia (Science)
- Allelic replacement in Staphylococcus aureus with inducible counter-selection. (Plasmid)
- Immune evasion by staphylococci (Nature Reviews Microbiology)
- Methicillin-resistant Staphylococcus aureus disease in three communities. (New England Journal of Medicine)
- Staphylococcal coagulase; mode of action and antigenicity.
- Survival of Staphylococcus aureus Inside Neutrophils Contributes to Infection1
- Metal Chelation and Inhibition of Bacterial Growth in Tissue Abscesses (Science)
- Cryopyrin activates the inflammasome in response to toxins and ATP (Nature)
- A comparison of the endotoxin biosynthesis and protein oxidation pathways in the biogenesis of the outer membrane of Escherichia coli and Neisseria meningitidis
Their papers
- Metal Chelation and Inhibition of Bacterial Growth in Tissue Abscesses (2008) — 840 citations
- Staphylococcus aureus Elaborates Leukocidin AB To Mediate Escape from within Human Neutrophils (2013) — 143 citations
- Cytotoxic Virulence Predicts Mortality in Nosocomial Pneumonia Due to Methicillin-Resistant Staphylococcus aureus. (2015) — 57 citations
- Staphylococcus aureus Leukocidin A/B (LukAB) Kills Human Monocytes via Host NLRP3 and ASC when Extracellular, but Not Intracellular (2015) — 131 citations
- Staphylococcus aureus targets the Duffy antigen receptor for chemokines (DARC) to lyse erythrocytes (2015) — 113 citations
- Staphylococcus aureus leukocidin ED contributes to systemic infection by targeting neutrophils and promoting bacterial growth in vivo (2011) — 162 citations
- Exploiting dominant‐negative toxins to combat Staphylococcus aureus pathogenesis (2016) — 64 citations
- Leukocidins: staphylococcal bi-component pore-forming toxins find their receptors (2017) — 311 citations
- Multivalent human antibody-centyrin fusion protein to prevent and treat Staphylococcus aureus infections. (2023) — 20 citations
- Genetic variation of staphylococcal LukAB toxin determines receptor tropism (2021) — 22 citations
- The cell envelope of Staphylococcus aureus selectively controls the sorting of virulence factors (2021) — 46 citations
- Identification of a domain critical for Staphylococcus aureus LukED receptor targeting and lysis of erythrocytes (2020) — 22 citations
- Targeting leukocidin-mediated immune evasion protects mice from Staphylococcus aureus bacteremia (2020) — 31 citations
- Staphylococcus aureus Impairs the Function of and Kills Human Dendritic Cells via the LukAB Toxin (2019) — 57 citations
- Staphylococcus aureus leukocidins target endothelial DARC to cause lethality in mice (2019) — 39 citations
- Identification of biologic agents to neutralize the bicomponent leukocidins of Staphylococcus aureus (2019) — 26 citations
- Staphylococcus aureus Leukocidin LukED and HIV-1 gp120 Target Different Sequence Determinants on CCR5 (2016) — 18 citations
- The Bicomponent Pore-Forming Leucocidins of Staphylococcus aureus (2014) — 266 citations
- Staphylococcus aureus leukotoxin ED targets the chemokine receptors CXCR1 and CXCR2 to kill leukocytes and promote infection. (2013) — 173 citations
- CCR5 is a receptor for Staphylococcus aureus leukotoxin ED (2012) — 279 citations